Chae Ji Seon, Park Hyunju, Ahn So-Hee, Han Eun-Chong, Lee Yoonjin, Kim Youn Jin, Ahn Eun-Jin, Oh Hye-Won, Lee Hyun Jung, Choi Chulhee, Choi Youn-Hee, Kim Won-Joong
Department of Anesthesiology and Pain Medicine, College of Medicine, Ewha Womans University, Seoul 07804, Republic of Korea.
Department of Physiology, Inflammation-Cancer Microenvironment Research Center, College of Medicine, Ewha Womans University, Seoul 07804, Republic of Korea.
Pharmaceutics. 2023 Feb 7;15(2):553. doi: 10.3390/pharmaceutics15020553.
Complex regional pain syndrome (CRPS) is a condition associated with neuropathic pain that causes significant impairment of daily activities and functioning. Nuclear factor kappa B (NFκB) is thought to play an important role in the mechanism of CRPS. Recently, exosomes loaded with super-repressor inhibitory kappa B (Exo-srIκB, IκB; inhibitor of NFκB) have been shown to have potential anti-inflammatory effects in various inflammatory disease models. We investigated the therapeutic effect of Exo-srIκB on a rodent model with chronic post-ischemia pain (CPIP), a representative animal model of Type I CRPS. After intraperitoneal injection of a vehicle, Exo-srIκB, and pregabalin, the paw withdrawal threshold (PWT) was evaluated up to 48 h. Administration of Exo-srIκB increased PWT compared to the vehicle and pregabalin, and the relative densities of p-IκB and IκB showed significant changes compared to the vehicle 24 h after Exo-srIκB injection. The levels of several cytokines and chemokines were reduced by the administration of Exo-srIκB in mice with CPIP. In conclusion, our results showed more specifically the role of NFκB in the pathogenesis of CRPS and provided a theoretical background for novel treatment options for CRPS.
复杂性区域疼痛综合征(CRPS)是一种与神经性疼痛相关的病症,会导致日常活动和功能严重受损。核因子κB(NFκB)被认为在CRPS的发病机制中起重要作用。最近,装载有超抑制因子κB抑制蛋白(Exo-srIκB,IκB;NFκB的抑制剂)的外泌体已被证明在各种炎症疾病模型中具有潜在的抗炎作用。我们研究了Exo-srIκB对慢性缺血后疼痛(CPIP)啮齿动物模型的治疗效果,CPIP是I型CRPS的代表性动物模型。腹腔注射溶媒、Exo-srIκB和普瑞巴林后,评估长达48小时的爪部撤离阈值(PWT)。与溶媒和普瑞巴林相比,Exo-srIκB给药可提高PWT,并且在注射Exo-srIκB后24小时,与溶媒相比,p-IκB和IκB的相对密度显示出显著变化。在患有CPIP的小鼠中,Exo-srIκB给药可降低几种细胞因子和趋化因子的水平。总之,我们的结果更具体地显示了NFκB在CRPS发病机制中的作用,并为CRPS的新型治疗选择提供了理论背景。